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A TRIBUTE TO COMGAN
Cardiovascular and Renal Progression Factors
in Chronic Kidney Disease:
A Colloquium in Honor of John H. Dirks
ISN World Congress of Nephrology
Singapore, June 26, 2005
INTRODUCTION
This Colloquium is being held in honor of Dr. John
Herbert Dirks. Table 1 summarizes John’s illustrious ed-
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ucational and academic career but I will leave the de-
tails to Dr. Robert Schrier, who will introduce John
again as the recipient of the first International Soci-
ety of Nephrology (ISN) Roscoe R. Robinson Award.
Instead, I will briefly focus on some of the primary
elements that characterize the life of this gifted and
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Table 1. John Herbert Dirks, M.D.
1933 Born, Winnipeg, Manitoba, Canada
1953 Graduated, University of Manitoba
1958 M.D. University of Manitoba
1957–1962 Medical Residency, Internal Medicine, Montreal
1962–1965 Fellow, Laboratory of Kidney and Electrolyte Metabolism, National Institutes of Health, Bethesda, MD
1965–1976 Assistant Professor, Associate Professor, and Professor of Medicine and Physiology, McGill University, Montreal; Director, Renal
and Electrolyte Division, Royal Victoria Hospital, Montreal
1976–1987 Chair, Department of Medicine, University of British Columbia, Vancouver
1987–1991 Dean, Faculty of Medicine, University of Toronto
1992–1994 Chair, National Council of Canada for Bioethics in Human Research
1994–1996 Rector, The Aga Khan University, Karachi, Pakistan
1994–Present Chair, International Society of Nephrology (ISN) Commission for the Global Advancement of Nephrology (COMGAN)
1992–Present President, The Gairdner Foundation
most giving Canadian physician, scientist, scholar, and
humanitarian.
Born and raised in modesty in the true Mennonite tra-
dition, which he has steadfastly maintained throughout
his life, John’s career has been marked by genuine and
consistent curiosity, bookishness, commitment to excel-
lence, and a grand vision of worldly scope. After training
in internal medicine in Montreal, he spent 3 productive
years in renal physiology research at National Institutes
of Health (NIH) where he made key discoveries on fluid
volume regulation. When he returned to Montreal to lead
the Renal Program at Royal Victoria Hospital, he and his
team made major contributions to our understanding of
the mechanism of action of diuretics and the role of the re-
nal tubule in calcium, phosphorus, and magnesium home-
ostasis. John then was invited to the Chair in Medicine at
the University of British Columbia where, over the next
11 years, he built a superb department with distinctions
in teaching and research. His leadership skills led to his
elevation to the Deanship of the University of Toronto
where he again served with great distinction, before em-
barking on a new career in international health, initially
in Toronto and then at Aga Khan University in Pakistan.
He similarly raised the standards, energy level, and inter-
national reputation of the once rather sleepy Gairdner
Foundation to a position of preeminence since assuming
its Presidency more than a decade ago. Indeed, under his
leadership, it is now the case that a person selected for
the Gairdner Award is virtually certain to be awarded the
Nobel Prize. Likewise, his superb leadership of the global
outreach effort of the ISN through its Commission for
the Global Advancement of Nephrology (COMGAN)
has made it a truly path-breaking vehicle for promoting
educational and practical training experiences for tens of
thousands of renal and related health care professionals
in virtually every corner of the globe.
Among many other initiatives forged by COMGAN
under his guidance, his efforts have made clear to in-
ternational health agencies that we are now experienc-
ing a sea-change in the world’s disease burden, namely,
no longer primarily from infectious diseases but rather
from chronic, progressive, and debilitating disorders such
as heart failure and chronic renal failure. For his hu-
mane and selfless acts, John has received the highest
recognition and praise from his professional colleagues
and deserves no less from this Society to which he has
given so much. In all the spheres cited above, progress
and forward momentum would never have been possi-
ble without his unbridled enthusiasm, diligence, and self-
sacrifice—qualities of citizenship and devotion to fulfill-
ing humankind’s greatest needs that set him apart as a
national and international treasure deserving of the high-
est forms of recognition. John, more than anyone I know,
embodies Ralph Waldo Emerson’s admonition, “Do not
go where the path may lead. Go instead where there is
no path and leave a trail.”
One such modest recognition is the convening of
today’s scientific session in his honor. The theme se-
lected, “Cardiovascular and Renal Progression Factors
in Chronic Kidney Disease,” reflects John’s keen interest
in global disease prevention, particularly the global dis-
eases such as cardiovascular and renal disease that now
account for much of the world’s morbidity and mortality
and for which beneficial intervention strategies are ur-
gently needed. To address these issues we have assembled
an outstanding roster of speakers, whose contributions
and expertise are forging the primary and secondary pre-
vention initiatives that are rapidly setting standards for
care around the world. In the papers that follow, these ini-
tiatives will be highlighted. Let me also take this occasion
to recognize the generous and unrestricted educational
grant from Amgen, Inc., that makes this colloquium and
publication possible.
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